AZ claims another Imjudo approval, in big first-line NSCLC market — Fake Eli Lilly Twitter account falsely claimed insulin 'free' — Medtech execs ‘rethink’ long-term strategies as care settings shift -- See more on our front page news http://bit.ly/w28kSd #astrazeneca #fda #lungcancer #nonsmallcelllungcancer #insulin #twitter #socialmedia #elililly #medtech #ambulatorycare #biotech #biopharma #biotechnology #pharma #pharmanews #cafepharma
#astrazeneca #FdA #lungcancer #nonsmallcelllungcancer #insulin #twitter #socialmedia #elililly #medtech #AmbulatoryCare #biotech #biopharma #biotechnology #pharma #pharmanews #cafepharma